Cefotaxime i.v. versus oral neomycin-erythromycin for prophylaxis of infections after colorectal operations.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001442:Bacteroides Infections / Q000517:prevention & control; D001441:Bacteroides fragilis; D002439:Cefotaxime / Q000627:therapeutic use*; D003106:Colon / Q000601:surgery*; D004359:Drug Therapy, Combination; D004917:Erythromycin / Q000627:therapeutic use*; D004927:Escherichia coli Infections / Q000517:prevention & control; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000627:therapeutic use*; D011446:Prospective Studies; D011897:Random Allocation; D012007:Rectum / Q000601:surgery*; D013530:Surgical Wound Infection / Q000517:prevention & control*
D004917:Erythromycin; D009355:Neomycin; D002439:Cefotaxime